The truth about the marketing and promotion of medicines

Despite what critics say, the U.S. biopharmaceutical industry spends three times more on the research and development (R&D) of new treatments and cures than on the marketing and promotion of medicines. Misleading claims on how much is spent on marketing and promotion perpetuate a narrative riddled with inaccurate data and information and results in policy proposals that can harm patients.
Source: The Catalyst - Category: Pharmaceuticals Tags: Research and Development Let's Talk About Cost Source Type: news